Atlas Trials

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping

Clinical trial NCT04928976 · COMPLETED

Trial details

NCT number
NCT04928976
Sponsor
Novoic Limited
Status
COMPLETED
Study type
OBSERVATIONAL
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer's Disease (Incl Subtypes)Mild Cognitive Impairment
Start date
2021-01-22
Primary completion
2021-07-30
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.